Pharmaceutical Technology

APRIL 28, 2023

Originally granted approval in its largest market, the US, in 2017, Ozempic has subsequently obtained approval for three distinct dosages, 0.5mg, 1.0mg, and 2.0mg, for the treatment of type 2 diabetes. It is forecast that Ozempic will sustain its sales growth over the next five years, with an expected annual sales figure of $17bn in 2029.

Diabetes 52

Diabetes Dosage Labelling Compounding 52

Express Pharma

AUGUST 1, 2023

Representing an innovative oral therapy that specifically targets and binds with high affinity to the IL-23R, JNJ-2113 is set to become a leading treatment for this debilitating, chronic condition, with a global sales forecast of $292 million by 2029, according to GlobalData. per cent for the placebo group, and 37.2 per cent, 58.1

Dosage 52

Dosage 52

PharmaShots

FEBRUARY 22, 2023

Active Ingredient: dulaglutide Dosage Forms & Strengths: Injection: 0.75 mL, 3 mg/0.5 In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026).

Diabetes 64

Diabetes Compounding Dosage Communication 64

Pharmaceutical Technology

MARCH 7, 2023

billion by 2029, registering a CAGR of over 8% during the forecast period of 2022-2029. There are also outside variables that can affect the flow of powders, requiring specific dosage methods to achieve the desired result. Recent analysis valued the market [i] at USD 8.5 billion in 2021, which is expected to reach $15.77

Dosage 52

Dosage Packaging Communication 52